Narcolepsy
Therapeutics Market study is providing you with the up-to-date, actionable market
information and projections with the latest impact of the Covid 19 outbreak. It
offers all the requisite data to support tactical business decisions and come
up with strategic growth plans. This study also proposes a comprehensive insight
into the development policies and plans in addition to manufacturing processes
and cost structures.
The global Narcolepsy
Therapeutics Market is anticipated to witness an exponential growth in the
forecast period. Narcolepsy is a prolonged neurological disorder related to
excessive daytime sleepiness (EDS), cataplexy, hypnagogic hallucinations, sleep
paralysis, and fragmented night sleep.
Factors such as rising
incidence across the globe, changing lifestyle, increasing research activities,
increasing awareness about the disease and the available treatment options, and
increasing healthcare expenditure are likely to drive the narcolepsy
therapeutics industry in the forthcoming period. On the other hand, high cost
and lack of awareness are anticipated to hinder the market growth in the
future.
Download Free Sample
Report Now @ https://www.millioninsights.com/industry-reports/narcolepsy-therapeutics-market/request-sample
Narcolepsy Therapeutics
market is segmented by type, product type, and geography. The market is
segmented by type as secondary narcolepsy, narcolepsy with cataplexy, and
narcolepsy without cataplexy. The “narcolepsy without cataplexy” segment
accounts for a prominent share in the market. It is likely to witness
substantial growth in the years to come. The factors that could be attributed
to the growth of the market include growing consciousness about excessive
daytime sleepiness (EDS) through numerous media.
Based on product type, the
market is segmented as sodium oxybate, central nervous system stimulants,
tricyclic antidepressants, selective serotonin reuptake inhibitor, and others.
The “sodium oxybate” segment accounts for a prominent share in the market. It
is likely to witness exuberant growth in the years to come. The factors that
could be attributed to the growth of the market are presence of favorable
reimbursement rules, and rising consciousness levels relating to the disease.
Europe is a leading region
in the market. It is likely to maintain its dominance in the forecast period
owing to factors such as governments’ initiatives with respect to research and
development and rising awareness among the population. Europe is followed by
the Asia-Pacific region owing to lifestyle changes, rising standard of living,
focus on healthcare expenses.
Key players operating in
the narcolepsy therapeutics market include Jazz Pharmaceuticals Plc, Teva
Pharmaceutical Industries Ltd., Ligand Pharmaceuticals, Inc., Gray mark
Healthcare, Inc., Arena Pharmaceuticals, Inc., Shire Plc, and Others. The
leading companies are involved in partnerships, mergers and acquisitions, and
joint ventures in order to boost the inorganic growth of the industry.
Know
More Insights @ https://newsonmarketblog.wordpress.com
No comments:
Post a Comment